Merck CEO says he’s confident in growth despite Gardasil ‘headwind’news2025-02-04T19:41:34+00:00February 4th, 2025|Endpoints News|
Illumina added to China’s blacklist following Biosecure Act, tariffsnews2025-02-04T17:00:18+00:00February 4th, 2025|Endpoints News|
Merck pauses Gardasil shipments to Chinanews2025-02-04T11:30:48+00:00February 4th, 2025|Endpoints News|
Biogen’s research chief talks China, neuropsychiatry and pipeline plannews2025-02-03T18:45:35+00:00February 3rd, 2025|Endpoints News|
Gazans Trek Home, and Trump’s Tariff Spat With Colombianews2025-01-27T11:00:35+00:00January 27th, 2025|The New York Times|
In China, Government Data on Drugs Blocked From Public After Backlashnews2025-01-27T10:51:18+00:00January 27th, 2025|The New York Times|
In China, Rare Dissent Over a Program to Save on Drug Costsnews2025-01-25T05:00:05+00:00January 25th, 2025|The New York Times|
Man Charged With Giving Fake Botox Injections That Sickened Clientsnews2025-01-22T23:30:04+00:00January 22nd, 2025|The New York Times|
Chinese startup begins first clinical trial using CRISPR to edit cells directly in the bone marrownews2025-01-22T20:02:34+00:00January 22nd, 2025|Endpoints News|
Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharmanews2025-01-22T10:48:58+00:00January 22nd, 2025|Endpoints News|
